Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Der KRAS-Mutationsstatus bestimmt den Nutzen. Info Onkol. 12, 75 (2009). https://doi.org/10.1007/BF03362661
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03362661